PRORSD1P

Across TCGA pan-cancer cohorts, PRORSD1P RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated PRORSD1P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher PRORSD1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PRORSD1P expression acts as an unfavorable survival marker, although some lineages such as READ and BLCA show a favorable association.

ACC, READ, and LGG are the cancer types where PRORSD1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.395	0.751	<.001	74	view →
READ	OS	Tertile	II,III,IV	0.719	0.256	.002	55	view →
LGG	DFS	Median	All	0.608	0.857	<.001	54	view →
BLCA	DFS	Median	All	0.679	0.550	<.001	46	view →
KIRC	DFS	Tertile	All	0.449	0.700	.001	43	view →
MESO	DFS	Median	IV	0.151	0.471	.001	42	view →
UVM	DFS	Quartile	III,IV	0.200	0.893	.003	38	view →
LIHC	DFS	Median	All	0.467	0.613	.001	35	view →
COAD	DFS	Tertile	All	0.404	0.654	.003	19	view →
UCS	OS	Tertile	II,III,IV	0.642	0.228	.029	18	view →
OV	DFS	Median	IV	0.397	0.223	.012	12	view →
BRCA	OS	Quartile	III,IV	0.962	0.826	.017	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

PRORSD1P–ACC (DFS)

Open the ACC breakdown →